NYSE · traded in Congress
McKesson MCK
$1,118.7562 +57.9162 (+5.46%) Nov 9, 2026 4:09 AM ET
Market value$129.2B
P/E ratio-
Analyst target$1,050.00
52-week range-
Avg volume1,130,057
Dividend yield-
Chart
Analyst ratings
- 15 buy
- 5 hold
- 0 sell
Low target$965.00
Average target$1,137.50
High target$1,260.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $110,957M | $3,956M | $1,218M | 1.1% | |
| $105,380M | $3,685M | $614M | 0.6% | |
| $96,295M | $4,044M | $1,682M | 1.8% | |
| $106,158M | $3,685M | $1,186M | 1.1% |
Congress trades in MCK
Members of Congress disclosed 3 transactions in MCK in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/08/2026 | Rick Larsen WA02 | Purchase | $1,001 - $15,000 | 7/12/2026 filing |
| 06/15/2026 | Jonathan Jackson IL01 | Sale | $1,001 - $15,000 | 7/15/2026 filing |
| 04/08/2026 | Elizabeth Fletcher TX07 | Partial sale | $1,001 - $15,000 | 5/1/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- McKesson stock rises 3.9% on a CVS extension to 2032; CVS was 24% of its $403 billion in sales Stocks · October 1, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
